$BVS: Bioventus is a $45 Target

NASDAQ:BVS   Bioventus Inc
I believe the price target for Bioventus can easily be $45. It is a new IPO for a company w/ 700+ employees, disruptive orthobiologics and surgical methods, and high growth potential. Support just needs to pickup. That said, please do your own due diligence and invest at your own risk. Everything I say is on an opinion based basis.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.